Skip to main content
Clinical Trials/CTRI/2023/07/055898
CTRI/2023/07/055898
Not yet recruiting
Phase 3

A randomized controlled comparative pilot study to evaluate the efficacy of Fucus vesiculosus mother tincture in the treatment of Hypertriglyceridemia versus conventional Atorvastatin

Central Council for Research in Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Central Council for Research in Homoeopathy
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Central Council for Research in Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • 1\.Men and women aged 20\-65 years.
  • 2\.Known case of Hypothyroid, Type 2 Diabetics and Hypertension with control under medication.
  • 3\.Other systemic disorders under control with treatment.
  • 4\.Women surgically sterile, post\-menopausal, are agreed to practice adequate contraception.
  • 5\.Written Informed consent from the patient.
  • 6\.Cases falling under Mild and Moderate \[20]category of Serum Triglyceride levels as per the classification of Endocrine Society 2010

Exclusion Criteria

  • 1\.Pregnancy, breastfeeding.
  • 2\.Cases with other uncontrolled systemic diseases like Hypothyroidism, Cardiovascular, Endocrinal diseases or systemic infections.
  • 3\.Low levels of Vitamin D.
  • 4\.Previous history of cardiovascular disease and cerebra stroke.
  • 5\.Suffering from known liver disorders.
  • 6\.Cases falling under Severe category of Serum Triglycerides levels as per the classification of Endocrine Society 2010\.

Outcomes

Primary Outcomes

Not specified

Similar Trials